NeuroPace (NASDAQ:NPCE) Price Target Raised to $14.00 at JPMorgan Chase & Co.
NeuroPace (NASDAQ:NPCE – Get Free Report) had its price target increased by equities researchers at JPMorgan Chase & Co. from $9.00 to $14.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target points to a potential […]
More Stories
M&T Bank Completes $1.5 Billion Senior Notes Offering
On December 17, 2024, M&T Bank Corporation successfully closed a public offering, raising a total of $1.5 billion through the...
Tripadvisor (NASDAQ: TRIP) Announces Agreement with Liberty TripAdvisor Holdings, Inc. Regarding Merger
Tripadvisor, Inc. has disclosed a significant agreement with Liberty TripAdvisor Holdings, Inc. in an 8-K filing submitted to the Securities...
Disc Medicine, Inc. (NASDAQ:IRON) CEO John D. Quisel Sells 12,791 Shares
Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) CEO John D. Quisel sold 12,791 shares of the company’s stock in...
Guidewire Software, Inc. (NYSE:GWRE) President John P. Mullen Sells 7,165 Shares of Stock
Guidewire Software, Inc. (NYSE:GWRE – Get Free Report) President John P. Mullen sold 7,165 shares of the stock in a...
3D Systems Co. (NYSE:DDD) EVP Charles W. Hull Sells 115,971 Shares of Stock
3D Systems Co. (NYSE:DDD – Get Free Report) EVP Charles W. Hull sold 115,971 shares of the company’s stock in...
Playtika Holding Corp. (NASDAQ:PLTK) Major Shareholder Holding Uk Ltd Playtika II Sells 75,923 Shares of Stock
Playtika Holding Corp. (NASDAQ:PLTK – Get Free Report) major shareholder Holding Uk Ltd Playtika II sold 75,923 shares of the...